Future Directions in CLL Treatment
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, offer closing thoughts on the future treatment landscape of chronic lymphocytic leukemia.
Cost Considerations for CLL Therapies
Experts on chronic lymphocytic leukemia discuss how to approach cost considerations and available resources for CLL treatments.
CLL: Supportive Care and Managing Adverse Effects With BTK Inhibitors
Insights on supportive care and approaches to managing adverse effects of BTK inhibitors in the treatment of chronic lymphocytic leukemia.
Head-to-Head Studies on BTK Inhibitors in CLL
CLL expert Lori A. Leslie, MD, gives a comprehensive overview of the ALPINE and ELEVATE-RR head-to-head studies of BTK inhibitors in CLL.
Treatment Considerations for Chronic Lymphocytic Leukemia
Lori A. Leslie, MD, an expert on CLL, talks about factors that influence treatment decisions.
Shared Decision-Making for CLL Treatment
CLL experts offer insights on shared decision-making with patients while selecting treatments.
BTK Inhibitors for Treatment of CLL
Lori A. Leslie, MD, an expert on chronic lymphocytic leukemia, provides a comprehensive overview of BTK inhibitors used in the treatment of CLL.
Multidisciplinary Care of Patients With CLL
Hoshiyuki Iida, APN, discusses his role in the multidisciplinary team in the treatment of patients with chronic lymphocytic leukemia.
Overview of Chronic Lymphocytic Leukemia
Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process.
